Climb Bio, Inc. (CLYM) vs Verastem, Inc. (VSTM)

Climb Bio, Inc. and Verastem, Inc. are both Biotechnology companies. Climb Bio, Inc. and Verastem, Inc. are of similar size ($694.6M and $682.9M). Climb Bio, Inc. has the higher net margin (0.00% vs −231.6%) and the lower return on invested capital (−71.7% vs 0.00%). Across the 13 metrics below, Climb Bio, Inc. leads on 11 and Verastem, Inc. on 2.

Valuation

Metric CLYM VSTM Biotechnology median
P/E n/m n/m 7.88
P/S n/m 8.89 11.47
P/B 3.71 15.56 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 8.29 10.73
Earnings yield (7.12%) (31.66%) (28.84%)
Free cash flow yield (5.99%) (20.85%) (23.03%)

Profitability

Metric CLYM VSTM Biotechnology median
Gross margin — 86.35% 65.16%
Operating margin 0.00% (182.57%) 0.00%
Net margin 0.00% (231.59%) 0.00%
Free cash flow margin 0.00% (185.31%) 0.00%
Return on equity (27.10%) (471.16%) (57.72%)
Return on assets (26.27%) (100.65%) (49.22%)
Return on invested capital (71.73%) 0.00% 0.00%

Growth

Metric CLYM VSTM Biotechnology median
Revenue growth (TTM) — 472.89% 5.64%
EPS growth (last fiscal year) 42.48% 17.49% —
Revenue growth, 5-year CAGR — 12.11% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLYM VSTM Biotechnology median
Debt to equity 0.00 1.48 0.00
Current ratio 31.45 2.25 4.73
Net debt to EBITDA 1.44 0.76 0.96

Dividend

Metric CLYM VSTM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLYM VSTM Biotechnology median
Market cap 682.92m 694.62m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack